Volume 129; Issue supp-S1

Thrombosis Research

Volume 129; Issue supp-S1
2

Preface

Year:
2012
Language:
english
File:
PDF, 45 KB
english, 2012
4

Risk assessment for cancer-associated thrombosis: What is the best approach?

Year:
2012
Language:
english
File:
PDF, 218 KB
english, 2012
6

Cancer in pregnancy: The role of thromboprophylaxis

Year:
2012
Language:
english
File:
PDF, 173 KB
english, 2012
7

Platelet CLEC-2 and podoplanin in cancer metastasis

Year:
2012
Language:
english
File:
PDF, 656 KB
english, 2012
8

Platelet systems biology using integrated genetic and proteomic platforms

Year:
2012
Language:
english
File:
PDF, 345 KB
english, 2012
9

Oncogenic regulation of tissue factor and thrombosis in cancer

Year:
2012
Language:
english
File:
PDF, 208 KB
english, 2012
10

Side effects of anti-angiogenic drugs

Year:
2012
Language:
english
File:
PDF, 194 KB
english, 2012
11

Current concepts in the management of disseminated intravascular coagulation

Year:
2012
Language:
english
File:
PDF, 287 KB
english, 2012
12

Transfusion issues in cancer patients

Year:
2012
Language:
english
File:
PDF, 224 KB
english, 2012
13

Acquired hemophilia in malignancy

Year:
2012
Language:
english
File:
PDF, 187 KB
english, 2012
14

Tissue factor isoforms in cancer and coagulation: May the best isoform win

Year:
2012
Language:
english
File:
PDF, 1.04 MB
english, 2012
15

Heparanase procoagulant activity

Year:
2012
Language:
english
File:
PDF, 383 KB
english, 2012
16

The protein C pathway in cancer metastasis

Year:
2012
Language:
english
File:
PDF, 428 KB
english, 2012
18

Risk and management of thrombosis in multiple myeloma

Year:
2012
Language:
english
File:
PDF, 205 KB
english, 2012
19

Splanchnic vein thrombosis: new risk factors and management

Year:
2012
Language:
english
File:
PDF, 198 KB
english, 2012
20

CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer

Year:
2012
Language:
english
File:
PDF, 202 KB
english, 2012
21

New and old anticoagulants in cancer

Year:
2012
Language:
english
File:
PDF, 210 KB
english, 2012
22

Measurement of the new anticoagulants

Year:
2012
Language:
english
File:
PDF, 538 KB
english, 2012
23

Low-molecular-weight heparin and survival in lung cancer

Year:
2012
Language:
english
File:
PDF, 206 KB
english, 2012
24

Mechanisms coupling thrombomodulin to tumor dissemination

Year:
2012
Language:
english
File:
PDF, 183 KB
english, 2012
25

Endothelial cell activation markers in cancer

Year:
2012
Language:
english
File:
PDF, 214 KB
english, 2012
26

Tissue factor proangiogenic signaling in cancer progression

Year:
2012
Language:
english
File:
PDF, 406 KB
english, 2012
27

Microparticles in tumor progression

Year:
2012
Language:
english
File:
PDF, 424 KB
english, 2012
28

Thromboprophylaxis in non-surgical cancer patients

Year:
2012
Language:
english
File:
PDF, 251 KB
english, 2012
29

Treatment of established thrombotic events in patients with cancer

Year:
2012
Language:
english
File:
PDF, 422 KB
english, 2012
32

TrypsinogenIV, a new player in tumor angiogenesis

Year:
2012
Language:
english
File:
PDF, 63 KB
english, 2012
33

Novel functions of TFPI isoforms in breast cancer cells

Year:
2012
Language:
english
File:
PDF, 84 KB
english, 2012
37

Studying cell-microenvironment interactions in a microfluidics model of tumor microcirculation

Year:
2012
Language:
english
File:
PDF, 795 KB
english, 2012
40

The effect of aspirin on cancer mortality

Year:
2012
Language:
english
File:
PDF, 69 KB
english, 2012
44

Use of vena cava filters in cancer patients in California

Year:
2012
Language:
english
File:
PDF, 256 KB
english, 2012
47

Rate and time course of thromboembolism events in cancer patients

Year:
2012
Language:
english
File:
PDF, 70 KB
english, 2012
61

T cells, tissue factor and malignancy

Year:
2012
Language:
english
File:
PDF, 63 KB
english, 2012
63

Alternatively spliced tissue factor triggers breast tumor growth

Year:
2012
Language:
english
File:
PDF, 87 KB
english, 2012
81

Hemorrhagic diathesis in a patient with multiple myeloma – case report

Year:
2012
Language:
english
File:
PDF, 174 KB
english, 2012
85

Immunomodulatory effects of vitamin K-antagonist acenocoumarol

Year:
2012
Language:
english
File:
PDF, 69 KB
english, 2012
89

Orally administered unfractionated heparin reduces lung tumour incidence in a rat model

Year:
2012
Language:
english
File:
PDF, 171 KB
english, 2012
96

Role of anticoagulant heparan sulfate in tumor angiogenesis of the uterine carcinoma

Year:
2012
Language:
english
File:
PDF, 148 KB
english, 2012
102

Venous thromboembolism in cancer patients

Year:
2012
Language:
english
File:
PDF, 64 KB
english, 2012
108

Risk of venous thromboembolism after hospitalisation with cancer: record linkage study

Year:
2012
Language:
english
File:
PDF, 168 KB
english, 2012
111

Variability of INR in a sample of cancer patients in the WARP trial

Year:
2012
Language:
english
File:
PDF, 64 KB
english, 2012
124

Follow up of thrombin-generation after prostate cancer surgery

Year:
2012
Language:
english
File:
PDF, 70 KB
english, 2012
126

PAR-2 activation induces migration but not proliferation of pancreatic cancer cells

Year:
2012
Language:
english
File:
PDF, 62 KB
english, 2012
130

Fibrinogen-like protein 2 (FGL-2) – a novel biomarker for cancer

Year:
2012
Language:
english
File:
PDF, 67 KB
english, 2012
136

Author Index

Year:
2012
File:
PDF, 168 KB
2012
137

Hemostatic factors, innate immunity and malignancy

Year:
2012
Language:
english
File:
PDF, 508 KB
english, 2012